Mirum Pharmaceuticals
IPOHome - Mirum Pharma
Public · Foster City, United States · Founded 2018 · $788.5M raised
- Headquarters
- Foster City, California
- Employees
- 201–500
- Founded
- 2018
- Business Model
- B2B
- Website
- mirumpharma.com
- Total Funding
- $788.5M
- Last Round
- $600.0M Convertible NoteMay 2026
- Rounds
- 3
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 4 funding rounds and 6 investors for this company. The full record is or through the API.
About
Mirum Pharmaceuticals is a high-growth rare disease biopharmaceutical company focused on advancing medicines for cholestatic liver diseases. Founded in 2018 in Foster City, California, the company commercializes LIVMARLI (maralixibat), approved for cholestatic pruritus in Alagille syndrome and progressive familial intrahepatic cholestasis, and is advancing volixibat, an IBAT inhibitor in late-stage development for primary sclerosing cholangitis and additional cholestatic conditions.
Summary
Mirum Pharmaceuticals is a Biotech company based in Foster City, United States, founded in 2018. It has raised $788.5M in total across 3 rounds, most recently a $600.0M Convertible Note round in May 2026. Investors include TCG Crossover, New Enterprise Associates and Deerfield Management.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
May 2026
Sign up to see all 4 events
Funding: Series A through Convertible Note. Amounts, valuations, and investors where available.
Investors
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/mirum-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/mirum-pharmaceuticals" alt="Mirum Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>